{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260601276401/en/Turn-Therapeutics-Reports-Interim-Analysis-Findings-and-Adaptive-Optimization-Strategy-from-Phase-2-GX-03-Trial-in-Moderate-to-Severe-Atopic-Dermatitis", "message": "News view counter 769841 successfully enlarged"}